Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Grimaldi

Showing results (391-400 of 410) with videos related to

Pageof 41
Sort By:
Journal of Translational Medicine|January 7, 2021
A monocentric phase I study of vemurafenib plus cobimetinib plus PEG-interferon (VEMUPLINT) in advanced melanoma patients harboring the V600BRAF mutationEster Simeone, Giosuè Scognamiglio, Mariaelena Capone, et al.
Cancers|April 30, 2021
Ipilimumab and Stereotactic Radiosurgery with CyberKnife<sup>®</sup> System in Melanoma Brain Metastases: A Retrospective Monoinstitutional ExperienceValentina Borzillo, Rossella Di Franco, Diana Giannarelli, et al.
Current Research in Translational Medicine|May 4, 2016
Body weight and risk of molecular breast cancer subtypes among postmenopausal Mediterranean womenA Crispo, M Montella, G Buono, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22B Fisher, S Anderson, D L Wickerham, et al.
European Journal of Cancer (Oxford, England : 1990)|October 9, 2013
Efficacy and safety of ipilimumab 3mg/kg in patients with pretreated, metastatic, mucosal melanomaMichele Del Vecchio, Lorenza Di Guardo, Paolo A Ascierto, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 16, 2015
No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon β1b therapy in relapsing-remitting multiple sclerosis (the ARIANNA study)Roberta Lanzillo, Mario Quarantelli, Carlo Pozzilli, et al.
Neurology|November 15, 2011
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantroneV Martinelli, E Cocco, R Capra, et al.
Journal of Endocrinological Investigation|June 25, 2022
Artificial intelligence-based radiomics on computed tomography of lumbar spine in subjects with fragility vertebral fracturesE Biamonte, R Levi, F Carrone, et al.
Cancer Immunology, Immunotherapy : CII|April 4, 2014
Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanomaEster Simeone, Giusy Gentilcore, Diana Giannarelli, et al.
Genes & Cancer|December 19, 2022
Pathogenesis to management of hepatocellular carcinomaBen L Da, Kelly I Suchman, Lawrence Lau, et al.
Pageof 41

Showing results (391-400 of 410) with videos related to

Sort By:
Pageof 41
Journal of Translational Medicine|January 7, 2021
A monocentric phase I study of vemurafenib plus cobimetinib plus PEG-interferon (VEMUPLINT) in advanced melanoma patients harboring the V600BRAF mutationEster Simeone, Giosuè Scognamiglio, Mariaelena Capone, et al.
Cancers|April 30, 2021
Ipilimumab and Stereotactic Radiosurgery with CyberKnife<sup>®</sup> System in Melanoma Brain Metastases: A Retrospective Monoinstitutional ExperienceValentina Borzillo, Rossella Di Franco, Diana Giannarelli, et al.
Current Research in Translational Medicine|May 4, 2016
Body weight and risk of molecular breast cancer subtypes among postmenopausal Mediterranean womenA Crispo, M Montella, G Buono, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22B Fisher, S Anderson, D L Wickerham, et al.
European Journal of Cancer (Oxford, England : 1990)|October 9, 2013
Efficacy and safety of ipilimumab 3mg/kg in patients with pretreated, metastatic, mucosal melanomaMichele Del Vecchio, Lorenza Di Guardo, Paolo A Ascierto, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 16, 2015
No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon β1b therapy in relapsing-remitting multiple sclerosis (the ARIANNA study)Roberta Lanzillo, Mario Quarantelli, Carlo Pozzilli, et al.
Neurology|November 15, 2011
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantroneV Martinelli, E Cocco, R Capra, et al.
Journal of Endocrinological Investigation|June 25, 2022
Artificial intelligence-based radiomics on computed tomography of lumbar spine in subjects with fragility vertebral fracturesE Biamonte, R Levi, F Carrone, et al.
Cancer Immunology, Immunotherapy : CII|April 4, 2014
Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanomaEster Simeone, Giusy Gentilcore, Diana Giannarelli, et al.
Genes & Cancer|December 19, 2022
Pathogenesis to management of hepatocellular carcinomaBen L Da, Kelly I Suchman, Lawrence Lau, et al.
Pageof 41